FEMYFEMASYS INC

Nasdaq femasys.com


$ 1.10 $ -0.03 (-2.65 %)    

Tuesday, 17-Sep-2024 15:59:25 EDT
QQQ $ 473.56 $ -2.41 (-0.51 %)
DIA $ 417.12 $ -0.87 (-0.21 %)
SPY $ 563.14 $ -1.99 (-0.35 %)
TLT $ 100.82 $ -0.57 (-0.56 %)
GLD $ 237.35 $ -0.63 (-0.26 %)
$ 1.12
$ 1.13
$ 1.08 x 100
-- x --
$ 1.09 - $ 1.14
$ 0.25 - $ 4.75
105,066
na
24.9M
$ 0.16
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-11-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-10-2022 09-30-2022 10-Q
9 08-10-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-24-2022 12-31-2021 10-K
12 11-12-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- Reuters

 hc-wainwright--co-reiterates-buy-on-femasys-maintains-12-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $12 price target.

 femasys-secures-strategic-distribution-partnerships-for-commercialization-of-femaseed-for-over-13m-in-spanish-market

Femasys, Inc., (NASDAQ:FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide wit...

Core News & Articles

- Reuters

 chardan-capital-maintains-buy-on-femasys-lowers-price-target-to-10

Chardan Capital analyst Keay Nakae maintains Femasys (NASDAQ:FEMY) with a Buy and lowers the price target from $12 to $10.

 hc-wainwright--co-maintains-buy-on-femasys-lowers-price-target-to-12

HC Wainwright & Co. analyst Emily Bodnar maintains Femasys (NASDAQ:FEMY) with a Buy and lowers the price target from $13...

 femasys-q2-2024-eps-021
Femasys Q2 2024 EPS $(0.21)
08/08/2024 12:42:53

 hc-wainwright--co-reiterates-buy-on-femasys-maintains-13-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $13 price target.

 hc-wainwright--co-reiterates-buy-on-femasys-maintains-13-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates Femasys (NASDAQ:FEMY) with a Buy and maintains $13 price target.

 femasys-q1-2024-gaap-eps-017-beats-019-estimate-sales-271140k-miss-776500k-estimate

Femasys (NASDAQ:FEMY) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.19) by 10...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION